| |
Effects and Recommendation :
Imatinib mesylate may increase serum levels of Simvastatin.
Monitor for signs and symptoms of adverse effects especially muscle weakness and cramping. Lower the dose of simivastatin if needed.
Severity of the interaction : 3/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Imatinib mesylate. Novartis, May 2001.
Publication : Imatinib mesylate by Product Information
> Product Information - -
|
|
|
|
|
